Research ArticleDrug Discovery and Translational Medicine
Using Target Engagement Biomarkers to Predict Clinical Efficacy of MetAP2 inhibitors
Pamela J Farrell, Christopher J Zopf, Huey-Jing Huang, Deepika Balakrishna, Corine Holub, James Bilakovics, Andrea Fanjul, Jennifer Matuszkiewicz, Artur Plonowski, Paul Rolzin, Urmi Barnerjee, Jacques Ermolieff, Zacharia Cheruvallath, Christopher McBride, Darian Bartkowski, Crystal Mazur, Alok Pachori and Christopher Larson
Journal of Pharmacology and Experimental Therapeutics September 19, 2019, jpet.119.259028; DOI: https://doi.org/10.1124/jpet.119.259028
Pamela J Farrell
1 Takeda California;
Christopher J Zopf
2 Takeda Boston;
Huey-Jing Huang
1 Takeda California;
Deepika Balakrishna
1 Takeda California;
Corine Holub
1 Takeda California;
James Bilakovics
1 Takeda California;
Andrea Fanjul
1 Takeda California;
Jennifer Matuszkiewicz
1 Takeda California;
Artur Plonowski
1 Takeda California;
Paul Rolzin
1 Takeda California;
Urmi Barnerjee
1 Takeda California;
Jacques Ermolieff
1 Takeda California;
Zacharia Cheruvallath
1 Takeda California;
Christopher McBride
1 Takeda California;
Darian Bartkowski
1 Takeda California;
Crystal Mazur
3 Florida Hospital
Alok Pachori
3 Florida Hospital
Christopher Larson
1 Takeda California;
Data Supplement
- Supplemental Data -
6 supplemental figures, 4 tables, and supplemental methods.